Apixaban lowers stroke risk in atrial fibrillation patients undergoing cardioversion (EMANATE), study suggests

Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to new research.